Deep learning for continuous manufacturing of pharmaceutical solid dosage form

被引:23
|
作者
Roggo, Yves [1 ]
Jelsch, Morgane [1 ]
Heger, Philipp [1 ]
Ensslin, Simon [1 ]
Krumme, Markus [1 ]
机构
[1] Novartis Pharma AG, Continuous Mfg CM Unit, WSJ 27-4-021-01, CH-4002 Basel, Switzerland
关键词
Continuous manufacturing; Solid dosage form; Process monitoring; Process analytical technology; Deep learning; Process data science; Process data analytics; PROCESS ANALYTICAL TECHNOLOGY;
D O I
10.1016/j.ejpb.2020.06.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Continuous Manufacturing (CM) of pharmaceutical drug products is a new approach within the pharmaceutical industry. In the presented paper, a GMP continuous wet granulation line for production of solid dosage forms was investigated. The line was composed of the subsequent continuous unit operations feeding - twin-screw wet-granulation - fluid-bed drying - sieving and tableting. The formulation of a commercial entity was selected for this study. Several critical process parameters were evaluated in order to probe the process and to characterize the impact on quality attributes. Seven critical process parameters have been selected after a risk analysis: API and excipient mass flows of the two feeders, liquid feed rate and rotation speed of the extruder and rotation speed, temperature and airflow of the dryer. Eight quality attributes were controlled in real time by Process Analytical Technologies (PAT): API content after blender, after dryer, in tablet press feed frame and of tablet LOD after dryer and PSD after dryer (three PSD parameters: x10 x50 x90). The process parameter values were changed during production in order to detect the impact on the quality of the final product. The deep learning techniques have been used in order to predict the quality attribute (output) with the process parameters (input). The use of deep learning reduces the noise and simplify the data interpretation for a better process understanding. After optimization, three hidden layers neural network were selected with 6 hidden neurons. The activation function ReLU (Rectified Linear Unit) and the ADAM optimizer were used with 2500 epochs (number of learning cycle). API contents, PSD values and LOD values were estimated with an error of calibration lower than 10%. The level of error allow an adequate process monitoring by DNN and we have proven that the main critical process parameters can be identified at a higher levelof process understanding. The synergy between PAT and process data science creates a superior monitoring framework of the continuous manufacturing line and increase the knowledge of this innovative production line and the products that it makes.
引用
收藏
页码:95 / 105
页数:11
相关论文
共 50 条
  • [1] Continuous manufacturing: the future in pharmaceutical solid dosage form manufacturing
    Desai, Parind Mahendrakumar
    Van Vaerenbergh, Griet
    Holman, Jim
    Liew, Celine Valeria
    Heng, Paul Wan Sia
    [J]. PHARMACEUTICAL BIOPROCESSING, 2015, 3 (05) : 357 - 360
  • [2] Continuous manufacturing process monitoring of pharmaceutical solid dosage form: A case study
    Roggo, Yves
    Pauli, Victoria
    Jelsch, Morgane
    Pellegatti, Laurent
    Elbaz, Frantz
    Ensslin, Simon
    Kleinebudde, Peter
    Krumme, Markus
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 179
  • [3] Development and applications of a material library for pharmaceutical continuous manufacturing of solid dosage forms
    Wang, Yifan
    O'Connor, Thomas
    Li, Tianyi
    Ashraf, Muhammad
    Cruz, Celia N.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 569
  • [4] Continuous powder feeding for pharmaceutical solid dosage form manufacture: a short review
    Blackshields, Caroline A.
    Crean, Abina M.
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2018, 23 (06) : 554 - 560
  • [5] Powder composition monitoring in continuous pharmaceutical solid-dosage form manufacturing using state estimation-Proof of concept
    Destro, Francesco
    Munoz, Salvador Garcia
    Bezzo, Fabrizio
    Barolo, Massimiliano
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 605
  • [6] Advances in solid dosage form manufacturing technology
    Andrews, Gavin P.
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES, 2007, 365 (1861): : 2935 - 2949
  • [7] Development of Formulation, Manufacturing Technology, and Standardization of Solid Pharmaceutical Dosage Form of Dilept, a Novel Atypical Neuroleptic
    Grushevskaya, L. N.
    Gusev, M., V
    Blynskaya, E., V
    Tikhonova, N., V
    Marachova, A., I
    Gaevaya, L. M.
    Avdyunina, N., I
    Alekseev, K., V
    Pyatin, B. M.
    Kondakov, S. E.
    [J]. MOSCOW UNIVERSITY CHEMISTRY BULLETIN, 2013, 68 (05) : 246 - 250
  • [8] Review of sensing technologies for measuring powder density variations during pharmaceutical solid dosage form manufacturing
    Stranzinger, S.
    Markl, D.
    Khinast, J. G.
    Paudel, A.
    [J]. TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2021, 135
  • [9] A Quality-by-Control Approach in Pharmaceutical Continuous Manufacturing of Oral Solid Dosage via Direct Compaction
    Su, Qinglin
    Ganesh, Sudarshan
    Dan Bao Le Vo
    Nukala, Anushaa
    Bommireddy, Yasasvi
    Gonzalez, Marcial
    Reklaitis, Gintaras V.
    Nagy, Zoltan K.
    [J]. 29TH EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING, PT B, 2019, 46 : 1327 - 1332
  • [10] A Systematic Framework for Process Control Design and Risk Analysis in Continuous Pharmaceutical Solid-Dosage Manufacturing
    Qinglin Su
    Mariana Moreno
    Arun Giridhar
    Gintaras V. Reklaitis
    Zoltan K. Nagy
    [J]. Journal of Pharmaceutical Innovation, 2017, 12 : 327 - 346